Co-beneldopa (Benserazide/levodopa) vs Cabergoline
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 245.2× as often as Cabergoline in May 2026 — 77,476 items versus 316 in England.
77,476items
Co-beneldopa (Benserazide/levodopa) · May 2026
NHSBSA Prescription Cost Analysis
316items
Cabergoline · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-beneldopa (Benserazide/levodopa) versus Cabergoline: national items dispensed by month
▬ Co-beneldopa (Benserazide/levodopa) · ╌ Cabergoline
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Co-beneldopa (Benserazide/levodopa) | Cabergoline |
|---|---|---|
| Items, May 2026 | 77,476 | 316 |
| Items, last 12 months | 948,791 | 4,092 |
| Net ingredient cost, May 2026 | £953,642 | £26,131 |
See the full profile for Co-beneldopa (Benserazide/levodopa) or Cabergoline.